Connect with others who understand.

sign up log in
About mySMAteam

Connect with others who understand.

sign up log in
About mySMAteam
SMA
NEWS

Breathing Remains Stable for Infants With SMA Type 1 Taking Spinraza, Study Shows

Posted on January 06, 2022
Medically reviewed by
Evelyn O. Berman, M.D.
Article written by
Brooke Dulka, Ph.D.

  • Nusinersen, sold as Spinraza, has been shown to prevent decline in breathing abilities in some infants with spinal muscular atrophy (SMA) type 1.
  • In a recent study, none of the infants receiving the treatment showed signs of improvement in their breathing after two years of treatment.
  • Researchers concluded that further real-world study is necessary to determine if starting treatment earlier will have better outcomes.

Infants with SMA type 1 treated with nusinersen can maintain the same level of breathing or respiration over two years, according to a new study. Typically, infants with SMA type 1 — the most severe form of the condition — experience a rapid decline in their breathing abilities as the condition progresses. The median survival for infants with SMA type 1 is 8 to 13.5 months. Respiratory failure is the most common cause of death.

Sold as Spinraza, nusinersen is the first disease-modifying therapy for SMA. It was approved by the U.S. Food and Drug Administration (FDA) in 2016.

For the study — conducted by Dr. Moran Lavie and their colleagues at Tel Aviv University in Israel — 20 infants with SMA type 1 were assessed both before and after two years of nusinersen treatment. Among the participants, 16 infants were already on assisted ventilation at the start of the study; the other four were not.

Share your thoughts with others. Click here to add a comment.

During the two years, the researchers observed several outcomes. These included:

  • All of the participants who were on ventilation when they started treatment remained clinically stable, maintaining a similar level and type of ventilatory support.
  • The four infants who were not on ventilation needed to start ventilation.
  • Two infants died from acute respiratory failure.
  • One infant sustained a severe brain injury.
  • Four of the infants had recurrent or chronic collapse of the lung.

“Our experience was that most patients were stable in their need for assisted ventilation and did not worsen as expected given the natural history of the disease, nor did they improve as one would hope,” the authors of the study wrote.

They noted that further studies are necessary to see whether starting treatment with nusinersen earlier might lead to better respiratory outcomes.

All updates must be accompanied by text or a picture.
Evelyn O. Berman, M.D. is a neurology and pediatric specialist and treats disorders of the brain in children. Review provided by VeriMed Healthcare Network. Learn more about her here.
Brooke Dulka, Ph.D. is a freelance science writer and editor. She received her doctoral training in biological psychology at the University of Tennessee. Learn more about her here.

Related articles

Spinal muscular atrophy (SMA) is a genetic, neuromuscular disorder. Because SMA is mostly driven...

Understanding How SMA Gene Therapy Works

Spinal muscular atrophy (SMA) is a genetic, neuromuscular disorder. Because SMA is mostly driven...
Spinal muscular atrophy (SMA) is a neuromuscular disorder that causes muscle weakness throughout...

Respiratory Equipment for SMA: What To Look For

Spinal muscular atrophy (SMA) is a neuromuscular disorder that causes muscle weakness throughout...
Until very recently, treatments for spinal muscular atrophy (SMA) could only manage symptoms....

Treatments for Spinal Muscular Atrophy (SMA)

Until very recently, treatments for spinal muscular atrophy (SMA) could only manage symptoms....
Physical therapy can help manage symptoms of SMA like contractures or scoliosis.There are...

Physical Therapy for SMA: How To Get the Most Out of PT

Physical therapy can help manage symptoms of SMA like contractures or scoliosis.There are...
About one-third of people with spinal muscular atrophy (SMA) are adults.Adults with SMA may have...

Treatment Options for Adults with SMA

About one-third of people with spinal muscular atrophy (SMA) are adults.Adults with SMA may have...
Costs for spinal muscular atrophy (SMA) medications are high, but financial assistance programs...

Tips for Staying on Spinal Muscular Atrophy (SMA) Therapies

Costs for spinal muscular atrophy (SMA) medications are high, but financial assistance programs...

Recent articles

The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month. This...

SMA Awareness Month Is Here!

The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month. This...
The Centers for Disease Control and Prevention (CDC) has approved a second COVID-19 booster shot...

What People With SMA Should Know About Getting a Second COVID-19 Booster Shot

The Centers for Disease Control and Prevention (CDC) has approved a second COVID-19 booster shot...
Historically, spinal muscular atrophy (SMA) has been difficult to diagnose. The doctors I saw as...

Learning Self-Advocacy at a Young Age: My Experiences

Historically, spinal muscular atrophy (SMA) has been difficult to diagnose. The doctors I saw as...
People in online gaming communities have a wide range of personalities, outlooks, and behaviors —...

Gaming With SMA: Beware of Trolls and Hackers

People in online gaming communities have a wide range of personalities, outlooks, and behaviors —...
Becoming a better gamer can enhance your enjoyment and expand your gaming opportunities. Getting...

Gaming With SMA: Leveling Up Your Gaming Skills

Becoming a better gamer can enhance your enjoyment and expand your gaming opportunities. Getting...
When you first get started with online gaming, finding friends can feel virtually impossible...

Gaming With SMA: Finding Friends in Online Gaming

When you first get started with online gaming, finding friends can feel virtually impossible...
SMA News
SMA News

Thank you for subscribing!

Become a member to get even more:

sign up for free

close